Skip to main content
Equibles

LPL Financial LLC

Position in HUMA — Humacyte, Inc.

CIK 1403438 FORT MILL, SC
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$799,917
+$275,188 QoQ
Shares Held
1,260,150
+12.1% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 163 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. HUMA ranks #73 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,111 $143,610,107
2 REGN
Regeneron Pharmaceuticals, Inc.
 65,755 $41,000,872
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 310,761 $25,330,129
4 ARGX
Argenx SE
 19,499 $18,090,587
5 ALNY
Alnylam Pharmaceuticals, Inc.
 57,890 $17,426,626
6 HALO
Halozyme Therapeutics, Inc.
 203,557 $15,932,406
7 RPRX
Royalty Pharma plc
 249,117 $13,967,990
8 INSM
INSMED Inc
 128,553 $13,706,320

All Filings in HUMA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $799,917 1,025,535
2026-03-31 $524,729 864,463
2025-12-31 $804,992 837,661
2025-09-30 $1,375,917 790,757
2025-06-30 $1,514,832 724,800
2025-03-31 $1,080,939 633,982
2024-12-31 $2,676,459 529,992
2024-09-30 $2,785,236 511,992
2024-06-30 $2,223,609 463,252
2024-03-31 $1,306,495 420,095
2023-12-31 $1,043,827 367,545
2023-09-30 $1,000,542 341,482
2023-06-30 $904,160 316,140
2023-03-31 $861,615 278,840
2022-12-31 $600,379 284,540
2022-09-30 $1,020,510 313,040
2022-06-30 $955,103 297,540
2021-12-31 $1,731,771 238,865
2021-09-30 $1,330,680 114,615